Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 11:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1657–1680 of 2,513 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Healthy Subjects (HS)
Interventions: zidebactam administered as a 1g (approximately 200 μCi) IV infusion over 1 hour; Drug
Lead sponsor: Wockhardt; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Diabetes
Interventions: Ramipril, Candesartan cilexetil, Allopurinol; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 21 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obesity
Interventions: Weight Management Program (WMP), Medication for chronic weight management (Rx); Other · Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: COVID - 19
Interventions: PA-001; Drug
Lead sponsor: PeptiDream Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Uterine Cancer, Rectal Cancer, Colon Cancer, Breast Cancer, Lung Cancer, Sarcoma, Cervix Cancer, Head and Neck Cancer, Anal Cancer, Liver Cancer, Gastric Cancer, Bladder Cancer
Interventions: HyperSight cone beam computed tomography (CBCT) scan, ETHOS 2.0; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Opioid-use Disorder
Interventions: TM buprenorphine, SUBLOCADE; Drug
Lead sponsor: Indivior Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Berlin, New Jersey

Conditions: Aortic Regurgitation, Mitral Regurgitation, Aortic Stenosis
Interventions: CMR, Quality of Life Questionnaire; Diagnostic Test · Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Neuromuscular Disease, Motor Neuron Disease, Inherited Neuromuscular Conditions, Inherited Neuropathies
Interventions: EIM testing, Nerve & muscle ultrasonography, Nerve conduction studies, Electromyography (EMG); Device
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 2 Years to 110 Years
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hypertension, Chronic Kidney Disease
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: 50 Years and older
Enrollment: 595 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 12
States / cities: Palo Alto, California • Denver, Colorado • Washington D.C., District of Columbia + 7 more

Conditions: Sepsis
Interventions: CNA Rapid Sepsis Dx; Diagnostic Test
Lead sponsor: Robert Ehrman; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 5
States / cities: Birmingham, Alabama • Detroit, Michigan • New York, New York

Conditions: Crohn's Disease (CD)
Interventions: Time Restricted Feeding; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Pregnancy, Labor Pain
Interventions: Routine oxytocin, Half-dose oxytocin; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 172 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hiatal Hernia
Interventions: Biosynthetic Mesh, Hiatal Hernia Repair; Device · Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2030
U.S. locations: 6
States / cities: Los Angeles, California • New Orleans, Louisiana • St Louis, Missouri + 1 more

Conditions: Healthy Volunteers
Interventions: quiet breathing, Hypocapnic Hyperventilation, Hypercapnic Hyperventilation, eucapnic hyperventilation; Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Helicobacter Pylori Infection, Post-Treatment, Efficacy
Interventions: PyloPlus UBT System, Histology, Rapid Urease Test, Comparator Breath Test, Stool Antigen Test; Combination Product · Diagnostic Test
Lead sponsor: ARJ Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Doral, Florida • Union City, New Jersey

Conditions: Lung Cancer Stage III
Interventions: AN0025; Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Midlife Obese Adults With Cognitive Decline
Interventions: Prolonged nightly fasting, Health Education Control; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 40 Years to 59 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Squamous Cell Carcinoma of the Oropharynx
Interventions: Radiation Therapy; Radiation
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 5
States / cities: Miami, Florida • Charlottesville, Virginia • Norfolk, Virginia + 1 more

Conditions: Obesity, Rapid Eating Style
Interventions: RePace Intervention, Usual Care Control; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 4 Years to 7 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Stroke, Brain Ischemia
Interventions: ThermoSuit Cooling Induction, Magnesium Sulfate, tPA, Propofol, Etomidate, Neurothrombectomy; Device · Drug · Procedure
Lead sponsor: Life Recovery Systems; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 4
States / cities: New Orleans, Louisiana • Danville, Pennsylvania • Wilkes-Barre, Pennsylvania + 1 more

Conditions: Type 2 Diabetes
Interventions: Sitagliptin, Basal Bolus, Metformin and Sitagliptin, Glargine, Glargine 50%, Glargine 80%; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 292 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 5
States / cities: Atlanta, Georgia • Ann Arbor, Michigan • Columbus, Ohio + 1 more

Conditions: Substance Use, HIV/AIDS, Older Adults, Behavioral Intervention, Infectious Disease
Interventions: Psycho-educational content (5 Minutes), Readiness Assessment (10 minutes), Goal-Setting (5 minutes), Identifying and prioritizing needs (5 minutes), Explanation of Peer Navigator and Session wrap (5 minutes); Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 3
States / cities: Gainesville, Florida • Jacksonville, Florida • Lake City, Florida

Conditions: Anorexia Nervosa, Bulimia Nervosa
Interventions: Imaging, fast, regulated meals; Other · Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: San Diego, California

Conditions: Colo-rectal Cancer
Interventions: Implementation Science Strategy; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 4
States / cities: Boston, Massachusetts • Brockton, Massachusetts • East Boston, Massachusetts + 1 more

Search by objective public record fields.

Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.

Impact of Diabetes on Left Ventricular Remodeling

Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity

PA-001 Ph.1 Study in Healthy and Elderly Subjects

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

SUBLOCADE Rapid Initiation Study

Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease

Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study

Preclinical Detection of Sepsis Early in Hospitalized Patients Following Surgery, Injury or Severe Illness

The Impact of Time Restricted Feeding in Crohn's Disease

Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes

Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair

Clinical Evidence of pH Dependent ß2 Adrenergic Transport Mechanisms in the Airway

PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study

A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants

Weight Reduction and Cognitive Health: Pilot Study Testing a Prolonged Testing Prolonged Fasting Among Obese, Stressed Mid-life Adults

HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma

Eating RePace Study

Helping Stroke Patients With ThermoSuit Cooling

Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes

Feasibility of SBIRT-PN

Neurobiology of Anorexia and Bulimia Nervosa

Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study